Hi Mac
just following up from your posts of a couple of days ago re the ODD and RPDD stats - thanks again. With apparently considerable discussion these days between prospective designees and the FDA to clear up issues before requests are submitted, applications for both designations - 70-90% - are approved....so seems also very likely ANP's request(s) will also be approved.
The chances of getting a Priority Review Voucher are, statistically, far less, but we can point to other requests such as Sarepta's that have been accepted with apparently far less justification than would be provided with an application for ATL 1102 for DMD.
Please keep providing us with your valuable insights. And Sam, I appreciate your insights as well - we all benefit, so keep 'em comin'.
Hi Macjust following up from your posts of a couple of days ago...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.003(3.90%) |
Mkt cap ! $72.12M | |||
| Open | High | Low | Value | Volume |
| 7.9¢ | 8.3¢ | 7.9¢ | $147.1K | 1.826M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300000 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 106165 | 2 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.0¢ |
Change
0.003 ( 3.90 %) |
||||
| Open | High | Low | Volume | ||
| 7.9¢ | 8.3¢ | 7.9¢ | 108394 | ||
| Last updated 15.59pm 08/05/2024 ? | |||||
| PER (ASX) Chart |